1. Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma
    Keiichi Koshizuka et al, 2017, Cancer Metastasis Rev CrossRef
  2. Exome Sequencing Identifies LOXL2 Mutation as a Cause of Familial Intracranial Aneurysm
    YaQiu Wu et al, 2017, World Neurosurgery CrossRef
  3. Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis
    Giulia Fregni et al, 2018, EBioMedicine CrossRef
  4. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Dominic Cosgrove et al, 2018, Kidney Int CrossRef
  5. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models
    Masakazu Yashiro et al, 2018, Human Cell CrossRef
  6. Quantitative proteomics implicates Rictor/mTORC2 in cell adhesion
    HAO WANG et al, 2018, J. Proteome Res. CrossRef
  7. Extracellular processing of lysyl oxidase-like 2 and its effect on amine oxidase activity
    Kazushi Okada et al, 2018, Biochemistry CrossRef
  8. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
    Bing Shao et al, 2018, J Cell Mol Med CrossRef
  9. Is This the Last Requiem for Simtuzumab?
    Peter Fickert, 2018, Hepatology CrossRef
  10. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis
    Rongkun Li et al, 2019, Mol Cancer CrossRef
  11. Future Medical Treatment of PSC
    Elisabeth Krones et al, 2019, Curr Hepatology Rep CrossRef
  12. null
    Nikolaos A. Afratis et al, 2019 CrossRef
  13. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
    Jiwoon Choi et al, 2019, Gut and Liver CrossRef
  14. Prognostic utility and clinical significance of lysyl oxidase‐like 2 protein expression in digestive system cancers
    Yi Zhang et al, 2019, J Cell Physiol CrossRef
  15. Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB
    Faranak Mahjour et al, 2019, Oncogenesis CrossRef
  16. Molecular dynamics simulations on human fibulin-4 mutants D203A and E126K reveal conformational changes in EGF domains potentially responsible for enhanced protease lability and impaired extracellular matrix assembly
    Takako Sasaki et al, 2019, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef
  17. Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses
    Jie Zhao et al, 2019, Sci Rep CrossRef
  18. 2-Aminomethylene-5-Sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth
    Deborah A Smithen et al, 2019, J. Med. Chem. CrossRef
  19. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links
    Sylvain D. Vallet et al, 2019, Essays Biochem. CrossRef
  20. Lysyl Oxidase: Its Diversity in Health and Diseases
    Suchitra Kumari et al, 2017, Ind J Clin Biochem CrossRef
  21. Induction of altered gene expression profiles in cultured bovine granulosa cells at high cell density
    Anja Baufeld et al, 2017, Reprod Biol Endocrinol CrossRef
  22. Abundant Expression of Lysyl Oxidase-like 2 Protein in Intrahepatic Bile Ducts of Infants With Biliary Atresia
    Stefany Honigbaum et al, 2019, Journal of Pediatric Gastroenterology and Nutrition CrossRef
  23. Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation
    Yingming Zhao et al, 2017 CrossRef
  24. A novel splice variant of LOXL2 promotes progression of human papillomavirus–negative head and neck squamous cell carcinoma
    Chao Liu et al, 2019, Cancer CrossRef
  25. Identification and characterization of the promoter of cancer-related gene LOXL2
    Xin Liu et al, 2019, Experimental Cell Research CrossRef
  26. LOXL2 Promotes Oncogenic Progression in Alveolar Rhabdomyosarcoma Independently of its Catalytic Activity
    Olga Almacellas-Rabaiget et al, 2020, Cancer Letters CrossRef
  27. Lysyl Oxidase Like‐2 (LOXL2): An Emerging Oncology Target
    Vriddhi Chopra et al, 2020, Adv. Therap. CrossRef
  28. Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma
    Keiichi Koshizuka et al, 2018, Oncotarget CrossRef
  29. MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
    Volker Ast et al, 2018, Oncotarget CrossRef
  30. Tumor suppressor genes and allele-specific expression: mechanisms and significance
    Evan A. Clayton et al, 2020, Oncotarget CrossRef
  31. LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2
    Hua Yu et al, 2020, Cell Death Differ CrossRef
  32. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway
    Xi Hong et al, 2019, Int J Oncol CrossRef
  33. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma
    Lays M. Sobral et al, 2020, Mol Oncol CrossRef
  34. Linking LOXL2 to Cardiac Interstitial Fibrosis
    Melisse Erasmus et al, 2020, IJMS CrossRef
  35. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma
    Lays Martin Sobral et al, 2020, Genes Cancer CrossRef
  36. The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
    Sylvain D. Vallet et al, 2020, Cancers CrossRef
  37. Microarray expression profile of mRNAs and long noncoding RNAs and the potential role of PFK-1 in infantile hemangioma
    Kaiying Yang et al, 2021, Cell Div CrossRef
  38. Targeting cancer metastasis with antibody therapeutics.
    Huilin Yang et al, 2021, Wiley Interdiscip Rev Nanomed Nanobiotechnol CrossRef
  39. LOXL2 Inhibitors and Breast Cancer Progression
    Sandra Ferreira et al, 2021, Antioxidants CrossRef
  40. Thorny ground, rocky soil: tissue-specific mechanisms of tumor dormancy and relapse
    Andrea R. Lim et al, 2021, Seminars in Cancer Biology CrossRef
  41. Comparing transcriptomic profiles from seven cell lines to elucidate liver metastatic potential
    Lindsay R. Dresang et al, 2021, Advances in Cancer Biology - Metastasis CrossRef
  42. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
    Utpreksha Vaish et al, 2021, IJMS CrossRef
  43. Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population
    Suchitra Kumari et al, 2021, Diagnostics CrossRef
  44. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
    Yingbiao Wu et al, 2022, Cerebrovasc Dis CrossRef
  45. Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification
    Chao Jiang et al, 2022, Front. Mol. Biosci. CrossRef
  46. Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness
    Rongkun Li et al, 2021, Cell Death Dis CrossRef
  47. Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity
    Kentaro Nishi et al, 2022, PLoS ONE CrossRef
  48. Scutellaria barbata D. Don inhibits cervical cancer cell proliferation, migration, and invasion via miR-195-5p/LOXL2 axis
    Shouyu Xue et al, 2022 CrossRef
  49. Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance
    Ana Popovic et al, 2022, Front. Oncol. CrossRef